Garner Thomas bought LXRX
February 8, 2024 · Form 4 insider transaction
Garner Thomas bought 227,130 shares of Lexicon Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
227,130
Price
$0.00
Total value
N/A
InsiderGarner Thomas
RoleOfficer
SecurityRestricted Stock Units
Transaction codeA: Grant or award
Transaction dateFebruary 8, 2024
Filing dateFebruary 12, 2024
Shares owned after227,130
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit represents a contingent right to receive one share of common stock.; Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.